Rencent Capital is a global investment company, which manages funds on a scale of tens of billions of RMB with a business team of more than 50.
Forward-looking layout: In overseas market, Recent Capital has achieved in-depth cooperation with celebrated international investment banks e.g. Morgan Stanley, Goldman Sachs, UBS to seize investment opportunities from primary and secondary markets of major economies. In the Chinese domestic market, Recent Capital has established a strategic partnership with well-knowninstitutions e.g. Sequoia Capital, Huagai Capital, FountainVest Partners, Greenwoods Asset Management, etc.
Focus on two directions: healthcare and innovative technology.
Rencent Capital has invested in more than 60 companies featuring distinct technologies and innovative business modes with high return potential, including unicorns e.g. Kwai, TikTok, We Doctor, Terminus, 58 Zhuanzhuan, I-Mab Biopharma etc.
Rencent Capital makes long-term investment concentrated in enterprises playing leading roles in profoundly transformative industries, helps them to improve their strategies and operation management with our global resources and autonomous system, in order to create long-term corporate value and realize outstanding investment performance.
Unlimited by investment tools such as shareholding or bond, private placement or open market etc., Recent Capital accompanies the enterprises in their growth with a strategic perspective.
A professional team rooted in China yet with an international perspective, all from top-tier investment institutions or first-rate investment banks, with offices in Mainland China, Hong Kong, USA, UK, Singapore, and Tokyo.